384 related articles for article (PubMed ID: 17266041)
1. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
[TBL] [Abstract][Full Text] [Related]
2. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B
Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301
[TBL] [Abstract][Full Text] [Related]
3. Y-box binding protein 1--a prognostic marker and target in tumour therapy.
Kosnopfel C; Sinnberg T; Schittek B
Eur J Cell Biol; 2014; 93(1-2):61-70. PubMed ID: 24461929
[TBL] [Abstract][Full Text] [Related]
4. YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT.
Kosnopfel C; Sinnberg T; Sauer B; Busch C; Niessner H; Schmitt A; Forchhammer S; Grimmel C; Mertens PR; Hailfinger S; Dunn SE; Garbe C; Schittek B
Mol Cancer Res; 2018 Jul; 16(7):1149-1160. PubMed ID: 29743296
[TBL] [Abstract][Full Text] [Related]
5. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
6. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
7. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
8. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Wang H; Sun R; Chi Z; Li S; Hao L
Mol Cell Biochem; 2017 Sep; 433(1-2):1-12. PubMed ID: 28382490
[TBL] [Abstract][Full Text] [Related]
9. XAF1 expression is significantly reduced in human melanoma.
Ng KC; Campos EI; Martinka M; Li G
J Invest Dermatol; 2004 Dec; 123(6):1127-34. PubMed ID: 15610524
[TBL] [Abstract][Full Text] [Related]
10. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.
Gunasekaran VP; Nishi K; Sivakumar D; Sivaraman T; Mathan G
Eur J Pharm Sci; 2018 Apr; 116():2-14. PubMed ID: 28916481
[TBL] [Abstract][Full Text] [Related]
11. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
12. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
13. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.
Jia J; Zheng Y; Wang W; Shao Y; Li Z; Wang Q; Wang Y; Yan H
Mol Med Rep; 2017 Jan; 15(1):240-248. PubMed ID: 27922666
[TBL] [Abstract][Full Text] [Related]
15. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
16. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA
Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
[TBL] [Abstract][Full Text] [Related]
17. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
Guay D; Garand C; Reddy S; Schmutte C; Lebel M
Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
[TBL] [Abstract][Full Text] [Related]
18. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.
Lu J; Li X; Wang F; Guo Y; Huang Y; Zhu H; Wang Y; Lu Y; Wang Z
Exp Cell Res; 2017 Oct; 359(2):319-326. PubMed ID: 28782557
[TBL] [Abstract][Full Text] [Related]
19. Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
Chua PJ; Lim JP; Guo TT; Khanna P; Hu Q; Bay BH; Baeg GH
Int J Oncol; 2018 Dec; 53(6):2579-2589. PubMed ID: 30221675
[TBL] [Abstract][Full Text] [Related]
20. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
